A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
https://www.jidonline.org/article/S0022-202X(20)30071-3/fulltext
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
https://www.jidonline.org/article/S0022-202X(20)30071-3/fulltext